These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness]. Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM; Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369 [TBL] [Abstract][Full Text] [Related]
5. The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness. Velligan DI; Weiden PJ; Sajatovic M; Scott J; Carpenter D; Ross R; Docherty JP; J Clin Psychiatry; 2009; 70 Suppl 4():1-46; quiz 47-8. PubMed ID: 19686636 [TBL] [Abstract][Full Text] [Related]
6. [French Society for Biological Psychiatry and Neuropsychopharmacology task force: Formal Consensus for the prescription of depot antipsychotics]. Samalin L; Abbar M; Courtet P; Guillaume S; Lancrenon S; Llorca PM Encephale; 2013 Dec; 39 Suppl 4():189-203. PubMed ID: 24373464 [TBL] [Abstract][Full Text] [Related]
7. Strategies for addressing adherence problems in patients with serious and persistent mental illness: recommendations from the expert consensus guidelines. Velligan DI; Weiden PJ; Sajatovic M; Scott J; Carpenter D; Ross R; Docherty JP J Psychiatr Pract; 2010 Sep; 16(5):306-24. PubMed ID: 20859108 [TBL] [Abstract][Full Text] [Related]
8. Assessment of adherence problems in patients with serious and persistent mental illness: recommendations from the Expert Consensus Guidelines. Velligan DI; Weiden PJ; Sajatovic M; Scott J; Carpenter D; Ross R; Docherty JP J Psychiatr Pract; 2010 Jan; 16(1):34-45. PubMed ID: 20098229 [TBL] [Abstract][Full Text] [Related]
9. Community adherence to schizophrenia treatment and safety monitoring guidelines. Keller WR; Fischer BA; McMahon R; Meyer W; Blake M; Buchanan RW J Nerv Ment Dis; 2014 Jan; 202(1):6-12. PubMed ID: 24375205 [TBL] [Abstract][Full Text] [Related]
10. The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder. Byerly MJ; Nakonezny PA; Rush AJ Schizophr Res; 2008 Mar; 100(1-3):60-9. PubMed ID: 18255269 [TBL] [Abstract][Full Text] [Related]
12. [Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists]. Misdrahi D; Delgado A; Bouju S; Comet D; Chiariny JF Encephale; 2013 May; 39 Suppl 1():S8-14. PubMed ID: 23541914 [TBL] [Abstract][Full Text] [Related]
13. Post-hoc analysis of two clinical trials examining Customized Adherence Enhancement plus long acting injectable antipsychotic (CAE-L) in high-risk individuals with serious mental illness. Collins CM; Aebi ME; Levin JB; Tatsuoka C; Cassidy KA; Sajatovic M Schizophr Res; 2018 Dec; 202():433-434. PubMed ID: 30032936 [No Abstract] [Full Text] [Related]
14. Evaluation of factors influencing medication compliance in inpatient treatment of psychotic disorders. Janssen B; Gaebel W; Haerter M; Komaharadi F; Lindel B; Weinmann S Psychopharmacology (Berl); 2006 Aug; 187(2):229-36. PubMed ID: 16710714 [TBL] [Abstract][Full Text] [Related]
15. Defining and assessing adherence to oral antipsychotics: a review of the literature. Velligan DI; Lam YW; Glahn DC; Barrett JA; Maples NJ; Ereshefsky L; Miller AL Schizophr Bull; 2006 Oct; 32(4):724-42. PubMed ID: 16707778 [TBL] [Abstract][Full Text] [Related]
16. Accuracy of Clinician Assessments of Medication Status in the Emergency Setting: A Comparison of Clinician Assessment of Antipsychotic Usage and Plasma Level Determination. Lopez LV; Shaikh A; Merson J; Greenberg J; Suckow RF; Kane JM J Clin Psychopharmacol; 2017 Jun; 37(3):310-314. PubMed ID: 28353490 [TBL] [Abstract][Full Text] [Related]
17. Monitoring and improving antipsychotic adherence in outpatient forensic diversion programs. Meyer JM CNS Spectr; 2020 Apr; 25(2):136-144. PubMed ID: 31120002 [TBL] [Abstract][Full Text] [Related]
18. Treatment adherence in schizophrenia and schizoaffective disorder. Goff DC; Hill M; Freudenreich O J Clin Psychiatry; 2011 Apr; 72(4):e13. PubMed ID: 21527119 [TBL] [Abstract][Full Text] [Related]
19. Twelve months of electronic monitoring (MEMS®) in the Swedish COAST-study: a comparison of methods for the measurement of adherence in schizophrenia. Brain C; Sameby B; Allerby K; Lindström E; Eberhard J; Burns T; Waern M Eur Neuropsychopharmacol; 2014 Feb; 24(2):215-22. PubMed ID: 24359935 [TBL] [Abstract][Full Text] [Related]
20. Low treatment adherence with antipsychotics is associated with relapse in psychotic disorders within six months after discharge. Laan W; van der Does Y; Sezgi B; Smeets HM; Stolker JJ; Wit NJ; Heerdink ER Pharmacopsychiatry; 2010 Aug; 43(6):221-4. PubMed ID: 20503150 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]